ונצואלה - ספרדית - Instituto Nacional de Higiene

astrazeneca venezuela, s.a. - metoprolol - comprimido - 23,75 mg

אורוגוואי - ספרדית - Ministerio de Salud (Dirección Oficina Central)

cibeles - solución inyectable - vacuna neumococo 23 serotipos (polisacáridos capsulares) 0,5 ml inyectable

האיחוד האירופי - ספרדית - EMA (European Medicines Agency)

laboratorios hipra, s.a. - mycoplasma hyopneumoniae, strain 7304 (nexhyon), expressing the capsid protein of porcine circovirus type 2a, inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - cerdos - for the active immunisation of pigs:to reduce lung lesions associated with porcine enzootic pneumonia caused by mycoplasma hyopneumoniae. also, to reduce the incidence of these lesions (as observed in field studies). to reduce viraemia, virus load in lungs and lymphoid tissues and the duration of the viraemic period associated with diseases caused by porcine circovirus type 2 (pcv2). efficacy against pcv2 genotypes a, b and d has been demonstrated in field studies. to reduce culling rate and the loss of daily weight gain caused by mycoplasma hyopneumoniae and/or pcv2 related diseases (as observed at 6 months of age in field studies). mycoplasma hyopneumoniae: onset of immunity: 3 weeks after vaccinationduration of immunity: 23 weeks after vaccinationporcine circovirus type 2:onset of immunity: 2 weeks after vaccinationduration of immunity: 22 weeks after vaccinationin addition, a reduction in nasal and faecal shedding and the duration of nasal excretion of pcv2 was demonstrated in animals challenged at 4 weeks and at 22 weeks after vaccination.

פרו - ספרדית - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

emcure pharma peru sociedad anonima cerrada - droguerÍa - tableta de liberacion prolongada - por mililitro - - metoprolol

גואטמלה - ספרדית - Gobierno de Guatemala, Ministerio de Salud Pública y Asistencia Social (Departamento de Regulación y Control de Productos Farmacéuticos y Afines)

productos del aire de guatemala - gas - 19.5-23.5%

האיחוד האירופי - ספרדית - EMA (European Medicines Agency)

zoetis belgium - inactivated mycoplasma hyopneumoniae, strain p-5722-3, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (orf2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein - inmunológicos para suidos - los cerdos (de engorde) - active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid tissues, fecal shedding and the lesions in lymphoid tissues associated with pcv2 infection. protection was demonstrated against porcine circovirus types 2a, 2b and 2d. active immunisation of pigs against mycoplasma hyopneumoniae to reduce the lung lesions associated with mycoplasma hyopneumoniae infection.  onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination.  duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination.  in addition, vaccination has been shown to reduce body weight gain losses under field conditions.

צ׳ילה - ספרדית - ISPC (Instituto de Salud Pública de Chile)

comercializadora crandon chile ltda. - tiametoxam 100% n°cas:153719-23-4 - tiametoxam 100% n°cas:153719-23-4 10,000 g - insecticidas para el control de moscas.

צ׳ילה - ספרדית - ISPC (Instituto de Salud Pública de Chile)

syngenta s.a. - thiametoxam 98% n°cas: 153719-23-4 - thiametoxam 98% n°cas: 153719-23-4 0,0102 g

צ׳ילה - ספרדית - ISPC (Instituto de Salud Pública de Chile)

merck sharp & dohme (i.a.) llc - polisacÁrido capsular purificado de streptococcus pneumoniae tipos: 1 (danÉs), 2 (danÉs), 3 (danÉs), 4 (danÉs), 5 (danÉs), 6b (danÉs), 7f (danÉs), 8 (danÉs), 9n (danÉs), 9v (danÉs), 10a (danÉs), 11a (danÉs), 12f (danÉs), 14 (danÉs), 15b (danÉs), 17f (danÉs), 18c (danÉs), 19a (danÉs), 19f (danÉs), 20 (danÉs), 22f (danÉs), 23f(danÉs), 33f (danÉs) 25,00 mcg - indicada para vacunar contra la enfermedad pneumocócica provocada por los tipos pneumocócicos incluidos en la vacuna. la efectividad de la vacuna para la prevención de la neumonía y la bacteriemia pneumocócica ha sido demostrada en estudios controlados realizados en sudáfrica y francia y en estudios de caso controlados. pneumovax 23 no prevendrá ninguna enfermedad provocada por tipos capsulares pneumocócicos diferentes a los contenidos en las vacuna.

צ׳ילה - ספרדית - ISPC (Instituto de Salud Pública de Chile)

anasac ambiental s.a. - tiametoxam 97% n°cas:153719-23-4 - tiametoxam 97% n°cas:153719-23-4 25,77 g - insecticidas contra rastreros; insecticidas contra voladores